Cambridge-based global, science-led biopharmaceutical company AstraZeneca and German manufacturer of viral vaccines and biologics IDT Biologika have signed a Letter of Intent (LOI) to increase Europe’s Covid-19 vaccine manufacturing capability.
Akron Biotechnology (Akron Biotech) has signed an exclusive global agreement with Swiss-based Octapharma, to manufacture virally inactivated Human AB Serum for the cell therapy market.
Gerresheimer is a speciality glass and plastics manufacturer for applications in the pharmaceutical packaging industry.
Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), announced a multi-year strategic collaboration with Novartis to reimagine this leading pharmaceutical company’s core pharmaceutical manufacturing, supply chain, and delivery operations using AWS’s portfolio of cloud services.
Data sharing specialist Nallian said that it will launch the Global Pharma Tracker, the world's first data sharing platform for end-to-end tracking and monitoring of temperature-controlled pharma shipments, at the IATA World Cargo Symposium in Singapore.
PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, has announced the expansion of its bottling line capacity at its Commercial Packaging site in Rockford, IL.
PCI Pharma Services (PCI) has announced further investment in its expansive infrastructure for packaging of controlled substances, complementing its capacity for blister packaging, a key tenet of recent calls for dispensing opioid prescriptions in limited quantity unit dose packaging as a tactic to combat substance misuse.
Swiss drugmaker Novartis has selected Kinaxis’ RapidResponse platform as its new supply chain planning system to accelerate technical operation transformation.
Schott, a Germany-based manufacturer of glass and glass-ceramics, has announced an investment of €300m in the coming three years in its pharmaceutical packaging business.
PCI Pharma Services (PCI) will invest over $20m to expand its biotech technologies, including advanced injectable delivery forms, at multiple locations across the world, to meet demand for biotech packaging.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.